Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Glimepiride, Alogliptin, and Alogliptin+Pioglitazone in T2DM
NCT04470310Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04470310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470310.